MedReconcile

Drug Interactions

Monitor and manage drug-drug interactions across all patients

1

Major Interactions

2

Moderate Interactions

0

Minor Interactions

Warfarin 5mg+Aspirin 81mg

Patient: John Smith · Detected 2026-01-28

majoractive

Aspirin may enhance the anticoagulant effect of warfarin, increasing the risk of bleeding.

Clinical Effect

Increased risk of gastrointestinal bleeding, intracranial hemorrhage, and other bleeding complications.

Management Strategy

If concurrent use is necessary, monitor INR more frequently. Consider gastroprotective therapy.

Lisinopril 10mg+Potassium Chloride

Patient: Robert Davis · Detected 2026-01-26

moderateactive

ACE inhibitors may increase the risk of hyperkalemia when combined with potassium supplements.

Management Strategy

Monitor serum potassium levels regularly.

Omeprazole 20mg+Clopidogrel 75mg

Patient: James Brown · Detected 2026-01-24

moderateactive

Omeprazole may reduce the antiplatelet effect of clopidogrel by inhibiting CYP2C19.

Management Strategy

Consider using pantoprazole instead, which has less CYP2C19 interaction.